The new board will work with Abzena's scientific and commercial leadership to provide strategic guidance and insights.

Lars Fruergaard Jørgensen will step down from his role as CEO of Novo Nordisk. In the meantime, a search for Jørgensen’s ...

Rznomics Inc., a South Korea-based biopharmaceutical company specializing in RNA-based therapeutics, has entered into a ...

BioMarin has entered into a definitive agreement to acquire Inozyme Pharma Inc. for a total consideration of approximately ...

Septerna, Novo Nordisk partner to discover, develop and commercialize oral small molecule medicines for cardiometabolic ...

Aptamer Group plc has announced two new development contracts for its Optimer binders and a licensing heads of terms ...

The partnership combines AKBA’s industry knowledge and product expertise with PeptiSystems’ next-generation synthesizers.

Manufacturing company groninger is investing over $14 million in new headquarters at its U.S. location in Charlotte, N.C.

AGC Biologics has partnered with Quell Therapeutics to support the development of multiple Treg cell therapy drug candidates.

Platinum Press Inc. (PPI) has commenced runs utilizing a digital printing system whose inks are free of volatile organic ...

Sanofi is the latest major pharmaceutical company to increase its investments in the U.S., partly in response to President ...

AbbVie and ADARx Pharmaceuticals have signed a collaboration and license option agreement to develop small interfering RNA ...